Trial intelligence / Profile preview

Lorazepam effects on fMRI task activation and resting-state signal stability in healthy young men

NL-OMON33167Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lorazepam, sponsored by University Medical Center Groningen. Primary endpoints: Working memory task performance, Episodic memory task performance and 4 more. Started Jul 2009; status: active, not recruiting.

02

Drugs

lorazepam

Beyond the preview

Go deeper on NL-OMON33167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call